Published in Klin Wochenschr on November 03, 1980
A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): an update. European NIDDM Policy Group. Diabet Med (1994) 2.78
Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med (1988) 2.27
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care (1997) 1.84
Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med (1992) 1.80
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia (1995) 1.63
Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med (1993) 1.51
Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis. Diabetologia (1995) 1.48
Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet Med (1998) 1.43
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients. Diabet Med (1991) 1.39
Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes (1979) 1.33
Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain (1988) 1.28
The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications (1992) 1.27
Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr (1988) 1.22
Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost (1991) 1.19
Metabolic and hormonal effects of muscular exercise in juvenile type diabetics. Diabetologia (1977) 1.17
Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab (1992) 1.15
Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes (1997) 1.13
Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes (1999) 1.13
Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care (1991) 1.13
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest (1990) 1.11
Steroid hormones and their binding in plasma of male patients with fatty liver, chronic hepatitis and liver cirrhosis. Acta Endocrinol (Copenh) (1975) 1.11
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry (1988) 1.06
Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol (1994) 1.05
Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration. Horm Metab Res (1980) 1.04
Noninvasive blood glucose sensors based on near-infrared spectroscopy. Artif Organs (1994) 1.04
Dietary-induced hypertrophic--hyperplastic obesity in mice. J Lipid Res (1974) 1.04
[13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia (1996) 1.01
Nutritional intake of 2868 IDDM patients from 30 centres in Europe. EURODIAB IDDM Complications Study Group. Diabetologia (1996) 1.01
Human health effects of dust exposure in animal confinement buildings. J Agric Saf Health (2000) 1.01
Enhanced conversion of androstenedione to estrogens in obese males. J Clin Endocrinol Metab (1980) 0.98
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes (1997) 0.96
Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Horm Metab Res (1997) 0.95
[Studies of gonadal function in patients with central diabetes insipidus (author's transl)]. J Neurovisc Relat (1971) 0.95
Thyroxine elimination by peritoneal dialysis in experimental thyrotoxicosis. Horm Metab Res (1973) 0.95
Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95
[Stability of steroids in plasma over a 10-year period]. J Clin Chem Clin Biochem (1985) 0.94
Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. The Diacan Multicenter Study Group. Diabete Metab (1993) 0.94
The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabet Med (1993) 0.94
[Osteocalcin and bone metabolism in rheumatoid arthritis and osteoarthritis]. Z Rheumatol (1987) 0.94
Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J (1984) 0.93
Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism (1978) 0.93
HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens (1976) 0.92
Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes (1988) 0.92
Relationship of plasma sex hormones to different parameters of obesity in male subjects. Metabolism (1980) 0.91
The natural course of peripheral and autonomic neural function during the first two years after diagnosis of type 1 diabetes. Klin Wochenschr (1988) 0.91
Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J (1979) 0.91
Follow-up of cyclosporin A treatment in type 1 (insulin-dependent) diabetes mellitus: lack of long-term effects. Diabetologia (1991) 0.89
Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. Ann N Y Acad Sci (1988) 0.89
Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabete Metab (1993) 0.89
[Peritoneal dialysis in the treatment of thyroid crisis]. Dtsch Med Wochenschr (1971) 0.88
Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia (1991) 0.88
Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med (1994) 0.88
Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care (1998) 0.87
Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia (1970) 0.87
Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative. Ann Nutr Metab (1991) 0.87
The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 0.87
Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis. Semin Thromb Hemost (1993) 0.86
A new serologic marker in ankylosing spondylitis. Arthritis Rheum (1984) 0.85
Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls. Immunobiology (1984) 0.85
Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients. Diabet Med (1992) 0.85
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients. Diabetologia (1998) 0.85
Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study. Eur J Clin Nutr (1997) 0.85
The effect of etomoxir on insulin sensitivity in type 2 diabetic patients. Horm Metab Res (1992) 0.84
Circadian and seasonal variations of glucocorticoid receptors in normal human lymphocytes. Steroids (1987) 0.83
LH- and FSH response to long-term application of LH-RH analogue in normal males. Horm Metab Res (1977) 0.83
[The effect of storage and temperature on the analysis of steroids in plasma and blood]. J Clin Chem Clin Biochem (1984) 0.83
Protein binding assays for 25-hydroxy, 24,25-dihydroxy and 1,25-dihydroxy metabolites of vitamin D1) in human plasma. J Clin Chem Clin Biochem (1981) 0.83
Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men. Horm Res (1976) 0.83
Evaluation of adrenal function in rats by the measurement of urinary free corticosterone, free aldosterone and free 11-deoxycorticosterone. Steroids (1978) 0.83
Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes (1995) 0.83
[A beta ray applicator (106Ru/106Rh) in the treatment of ciliary body melanomas]. Klin Monbl Augenheilkd (1985) 0.83
Endothelin-1 inhibits the adipose differentiation of cultured human adipocyte precursor cells. Metabolism (1994) 0.82
Possible age-dependent influence of estrogens on the binding of testosterone in plasma of adult men. Horm Metab Res (1974) 0.82
Free triiodothyronine (t3)- and thyroxine (t4) serum levels in old age. Horm Metab Res (1974) 0.82
Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia (1984) 0.82
Increased GPIIB/IIIA expression and altered DNA-ploidy pattern in megakaryocytes of diabetic BB-rats. Eur J Clin Invest (1992) 0.82